Industry LifeHealthInsurance
A dividend of $0.29 per share will be paid with a record date of September 25, 2026, and an ex-dividend date of September 10, 2026. The last dividend of $0.29 was paid on June 25, 2026. The ex-dividend date is usually set several business days before the record date. If a stock is purchased on its ex-dividend date or after, the next dividend payment will not be received. Instead, the dividends are repossessed by to the seller. If the stocks are purchased before the ex-dividend date, the buyer will receive the dividends.
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHFAM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BHFAM's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 24, 2026. You may want to consider a long position or call options on BHFAM as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BHFAM just turned positive on August 24, 2026. Looking at past instances where BHFAM's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
BHFAM moved above its 50-day moving average on September 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BHFAM crossed bullishly above the 50-day moving average on September 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BHFAM advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .
BHFAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BHFAM's P/B Ratio (0.000) is slightly lower than the industry average of (1.414). P/E Ratio (0.000) is within average values for comparable stocks, (21.319). BHFAM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.161). BHFAM has a moderately high Dividend Yield (0.113) as compared to the industry average of (0.044). BHFAM's P/S Ratio (0.000) is slightly lower than the industry average of (1.317).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BHFAM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHFAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.